Welcome back to Action Potential, join us this week as we welcome Dr. Deborah Clegg, VP of Research at Texas Tech University.

What you'll get from this episode:

• Dr. Deborah Clegg's journey from dietitian to VP of research at Texas Tech University.
• The vital role of nutrition in managing cardio-renal metabolic diseases.
• Importance of real-time data for empowering patients with kidney disease.
• Challenges and potential of biosensors for continuous potassium monitoring.
• Advocacy for re-evaluating dietary guidelines for kidney disease patients.

Thank you to our sponsor ProtonIntel: “At ProtonIntel, we are building the first real-time, continuous potassium monitoring wearable, allowing clinicians to treat and manage kidney disease patients more safely and precisely. Life-saving treatments that cannot be deployed when patients have dangerous K+ levels today will be unlocked for safe and optimal use."

Follow Action Potential: https://www.linkedin.com/company/action-potential-podcast/about/

This show is part of the Slice of Healthcare podcast network: https://www.linkedin.com/company/sliceofhealthcare/

Welcome back to Action Potential, join us this week as we welcome Lilian Okonkwo, Senior Director of Hospital Services at Strive Health.

What you'll get from this episode:

• Patient Vulnerability and Education: Lilian Okonkwo emphasizes the crucial role of patient education in acute care settings, particularly for those with chronic kidney disease (CKD) and end-stage kidney disease (ESKD). The moment of hospitalization often marks a point of vulnerability and openness to learning about their condition and treatment options.
• Transition to Value-Based Care Programs: The transition from hospital to value-based care programs is highlighted as a vital step in managing kidney disease. These programs focus on continuous education and care coordination, which are key to reducing hospital readmissions and improving patient outcomes.
• Dietary Guidance and Medication Management: A significant part of managing kidney disease involves educating patients about diet and medication. Value-based care provides resources like dietitians and medication management to help patients slow disease progression and manage their condition effectively.
• Importance of Remote Monitoring: Lilian Okonkwo discusses the potential of remote monitoring in kidney care, especially for tracking vital parameters like creatinine and potassium levels. This technology could enable better disease management and prevent hospital readmissions.
• Future Aspirations in Kidney Care: The conversation concludes with a hopeful outlook on future advancements in kidney care, including new technologies and approaches to managing the disease more effectively and improving patient quality of life.

Thank you to our sponsor ProtonIntel: “At ProtonIntel, we are building the first real-time, continuous potassium monitoring wearable, allowing clinicians to treat and manage kidney disease patients more safely and precisely. Life-saving treatments that cannot be deployed when patients have dangerous K+ levels today will be unlocked for safe and optimal use."

Learn more about Lilian Okonkwo: https://www.linkedin.com/in/lilian-okonkwo-msn-rn-agnp-bc-b646064a/

Follow Action Potential: https://www.linkedin.com/company/action-potential-podcast/about/

This show is part of the Slice of Healthcare podcast network: https://www.linkedin.com/company/sliceofhealthcare/

Welcome back to Action Potential, join us this week as we welcome Bill Van Antwerp, Founder and CSO at Laxmi, a leading expert in diabetes care.

What you'll get from this episode:

• Trailblazing in Remote Physiological Monitoring: Bill Van Antwerp shares his extensive experience in developing insulin pumps and the first FDA-approved CGM (Continuous Glucose Monitor), paving the way for modern diabetes care.
• Innovative Solutions Overcoming Manufacturing Challenges: Van Antwerp discusses the complex journey from concept to mass production, highlighting the difficulty in manufacturing reliable, consistent sensors at scale.
• The Evolution of CGM Technology: He reflects on the evolution of CGM, from initial skepticism and regulatory hurdles to its current status as a standard care tool for managing diabetes.
• Patient Empowerment through Technology: Van Antwerp emphasizes how CGMs have empowered patients, particularly in making informed decisions based on real-time data, a significant shift from the earlier FDA restrictions.
• Future Directions in Sensor Technology: Looking ahead, Van Antwerp discusses the potential of non-invasive methods and the importance of directly measuring targeted analytes for accurate and clinically actionable data.

Thank you to our sponsor ProtonIntel: “At ProtonIntel, we are building the first real-time, continuous potassium monitoring wearable, allowing clinicians to treat and manage kidney disease patients more safely and precisely. Life-saving treatments that cannot be deployed when patients have dangerous K+ levels today will be unlocked for safe and optimal use."

Learn more about Bill Van Antwerp: https://www.linkedin.com/in/bill-van-antwerp-35848052/

Follow Action Potential: https://www.linkedin.com/company/action-potential-podcast/about/

This show is part of the Slice of Healthcare podcast network: https://www.linkedin.com/company/sliceofhealthcare/

Welcome back to Action Potential, join us this week as we welcome Dr. George Bakris, Faculty at the American Society of Nephrology, a leading expert in nephrology and clinical pharmacology, on managing kidney care, hypertension, and diabetes.

What you'll get from this episode:

• Dr. George Bakris, discusses his expertise in nephrology and clinical pharmacology
• In-depth discussion on managing kidney disease, hypertension, and diabetes
• Insights into the impact of obesity, diet, and medications on kidney health
• Importance of patient education and therapy management in chronic kidney diseases
• Key takeaways for healthcare professionals and those affected by these conditions

Thank you to our sponsor ProtonIntel: “At ProtonIntel, we are building the first real-time, continuous potassium monitoring wearable, allowing clinicians to treat and manage kidney disease patients more safely and precisely. Life-saving treatments that cannot be deployed when patients have dangerous K+ levels today will be unlocked for safe and optimal use."

Learn more about Dr. George Bakris: https://www.linkedin.com/in/george-bakris-md-f-a-h-a-f-a-s-n-14050612/

Follow Action Potential: https://www.linkedin.com/company/action-potential-podcast/about/

This show is part of the Slice of Healthcare podcast network: https://www.linkedin.com/company/sliceofhealthcare/

Welcome back to Action Potential, join us this week as we welcome Dr. Jeff Wessler, CEO of Heartbeat Health as we explore and discover the future of cardiology.

What you'll get from this episode:

• Dr. Jeff Wessler discusses the transformative role of telemedicine in cardiology.
• Insights on Heartbeat Health's approach to remote patient care.
• The impact of COVID-19 on healthcare technology and patient experiences.
• Future trends in cardiology and healthcare technology.

Thank you to our sponsor ProtonIntel: “At ProtonIntel, we are building the first real-time, continuous potassium monitoring wearable, allowing clinicians to treat and manage kidney disease patients more safely and precisely. Life-saving treatments that cannot be deployed when patients have dangerous K+ levels today will be unlocked for safe and optimal use."

Learn more about Dr. Jeff Wessler: https://www.linkedin.com/in/jeffrey-wessler/

Follow Action Potential: https://www.linkedin.com/company/action-potential-podcast/about/

This show is part of the Slice of Healthcare podcast network: https://www.linkedin.com/company/sliceofhealthcare/

Welcome back to Action Potential, join us this week as we welcome David Rush, a renowned patient advocate, musician, and motivational speaker

What you'll get from this episode:

• Introduction: David Rush, patient advocate and motivational speaker, shares his journey with kidney disease.
• Personal Battle: Insight into David's diagnosis in 2006, his experience with dialysis, and his life-changing kidney transplant in 2010.
• Family and Community Support: The crucial role of support systems in navigating kidney disease.
• Advocacy and Motivation: David's work in spreading hope and advocating for kidney health.
• Innovations in Kidney Care: Discussion on advancements and the future of kidney health.
• Conclusion: David's message of resilience, hope, and the importance of community support.

Thank you to our sponsor ProtonIntel: “At ProtonIntel, we are building the first real-time, continuous potassium monitoring wearable, allowing clinicians to treat and manage kidney disease patients more safely and precisely. Life-saving treatments that cannot be deployed when patients have dangerous K+ levels today will be unlocked for safe and optimal use."

Learn more about David Rush: https://www.linkedin.com/in/david-rush-993149125/

Follow Action Potential: https://www.linkedin.com/company/action-potential-podcast/about/

Welcome back to Action Potential, join us this week as we welcome Dr. Craig Beavers, Associate Professor, UK College of Pharmacy

What you'll get from this episode:

• The journey to becoming a clinical pharmacist.
• Managing heart failure and cardio-oncology.
• Navigating polypharmacy challenges in patient care.
• The evolving role of clinical pharmacists in healthcare.
• The importance of patient-focused care and medication management.
• Future advancements in clinical pharmacy and patient monitoring.

Thank you to our sponsor ProtonIntel: “At ProtonIntel, we are building the first real-time, continuous potassium monitoring wearable, allowing clinicians to treat and manage kidney disease patients more safely and precisely. Life-saving treatments that cannot be deployed when patients have dangerous K+ levels today will be unlocked for safe and optimal use."

Learn more about Craig Beavers: https://www.linkedin.com/in/craig-beavers-pharmd-facc-faha-fccp-bccp-cacp-420b0a68/
And for more on UK College of Pharmacy: https://pharmacy.uky.edu/

Follow Action Potential: https://www.linkedin.com/company/action-potential-podcast/about/

Welcome back to Action Potential, join us this week as we welcome Dr. Shaminder Gupta, Chief Medical Officer, of Monogram Health

What you'll get from this episode:

• Introducing Dr. Shaminder Gupta and his vision for chronic kidney disease (CKD) management
• The story of Monogram Health and its evolution in the healthcare industry
• The impact of patient-centered care and in-home treatment models for CKD patients
• The role of interdisciplinary collaboration in providing cohesive care
• The potential and benefits of remote physiological monitoring for CKD
• Dr. Gupta's thoughts on the future of nephrology and patient care

Thank you to our sponsor ProtonIntel: “At ProtonIntel, we are building the first real-time, continuous potassium monitoring wearable, allowing clinicians to treat and manage kidney disease patients more safely and precisely. Life-saving treatments that cannot be deployed when patients have dangerous K+ levels today will be unlocked for safe and optimal use."

Learn more about Dr. Gupta: https://www.linkedin.com/in/dr-shaminder-gupta-182096197/
And for more on Monogram Health: https://www.monogramhealth.com/

Follow Action Potential: https://www.linkedin.com/company/action-potential-podcast/about/

Welcome back to Action Potential, join us this week as we welcome Dr. Paul Komenda, Chief Medical Officer, of Quanta Dialysis Technologies

What you'll get from this episode:

• Dr. Paul Komenda's path from nephrologist to dialysis tech innovator.
• Home hemodialysis program initiated by Dr. Komenda in Winnipeg.
• Impact of remote physiological monitoring in home hemodialysis.
• Technology's role in individualized education and support for CKD patients.
• Need for policy frameworks and investments to drive CKD care innovations.
• Envisioning nephrology's future with tech advancements and multidisciplinary collaboration.

Thank you to our sponsor ProtonIntel: “At ProtonIntel, we are building the first real-time, continuous potassium monitoring wearable, allowing clinicians to treat and manage kidney disease patients more safely and precisely. Life-saving treatments that cannot be deployed when patients have dangerous K+ levels today will be unlocked for safe and optimal use."

Learn more about Dr. Komenda: https://www.linkedin.com/in/paul-komenda-9536a924/?originalSubdomain=ca
And for more on Quanta Dialysis Technologies: https://www.quantadt.com/

Follow Action Potential: https://www.linkedin.com/company/action-potential-podcast/about/

Join us this week as we welcome Dr. Mandeep Sahani, Chief Medical Officer of TeleNeph LLC.

What you'll get from this episode:

• Dr. Sahani's journey in the field of nephrology and his 20+ years of experience.
• The challenges and rewards of serving underserved populations.
• The role of technology in empowering patients and improving kidney care.
• The importance of early intervention and education in managing CKD.
• A look into the future: The potential of home dialysis and the promise of tech advancements.

Huge thanks to our sponsor ProtonIntel: “At ProtonIntel, we are building the first real-time, continuous potassium monitoring wearable, allowing clinicians to treat and manage kidney disease patients more safely and precisely. Life-saving treatments that cannot be deployed when patients have dangerous K+ levels today will be unlocked for safe and optimal use."

Learn more about Dr. Sahani: https://www.linkedin.com/in/mandeep-sahani-71784753/
And for more on Teleneph: https://telenephllc.com/

Follow Action Potential: https://www.linkedin.com/company/action-potential-podcast/about/